Demant A/S

3 Decision Makers · 7 Verified Contacts

📍 Smørumnedre, Hovedstaden, DenmarkHealthcare & Medical🗓 Est. 1904👥 Above 10001 employees

About Demant A/S

Demant is the only company in the world that covers all areas of hearing healthcare, from hearing devices and hearing implants.

Leadership & Decision Makers

Contact details of 3 Demant A/S decision makers

Ulrik Hjorth

SVP Finance

Søren Nielsen

President & CEO

René Schneider

Chief Financial Officer

Team & Specialists

Contact details of 4 Demant A/S team members

Peter Soelberg

LinkedIn
  • Work email

    p**e@demant.com

Janne Jakobsen

Vice Presiden Oticon Brand, Global

Piotr Stapp

Software Architect

Elish Melchiade

Salesforce Project Manager & Scrum Master

General Emails

General company emails, e.g. customer support lines

    info@demant.com

    General Inquiries

    postmaster@demant.com

    Unclassified inbox

    william@demant.com

    Unclassified inbox

    mika@demant.com

    Unclassified inbox

    pepu@demant.com

    Unclassified inbox

    niov@demant.com

    Unclassified inbox

Similar Companies like Demant A/S

Medtronic

medtronic.com
Biotechnology · Minneapolis, MN · Est. 1949 · Above 10001 employees

HQ: Minneapolis, MN

Dexcom

dexcom.com
Healthcare & Medical · San Diego, CA · Est. 1999 · 5001–10000 employees

HQ: San Diego, CA

AbbVie

abbvie.com
Biotechnology · North Chicago, Illinois, United States · Est. 2013 · Above 10001 employees

HQ: North Chicago, Illinois, United States

Biotechnology · New York, NY · Est. 1849 · Above 10001 employees

HQ: New York, NY

Merck

merck.com
Biotechnology · Rahway, New Jersey, United States · Est. 1891 · Above 10001 employees · $1B–$1000B

HQ: Rahway, New Jersey, United States

Explore similar firms in the Healthcare & Medical sector

Company Info

Last updated: 27/07/2025

+45 3917 7300

Smørumnedre, Hovedstaden, Denmark

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Founded Date: 1904
Company Type: For Profit
Stock Symbol: CPH:WDH
Operating Status: Active
Last Funding Type: Post-IPO Debt
Phone Number: +45 3917 7300
Last Investment Activity: Aug 16, 2023
Investments Activity: Aug 16, 2023 Mar 29, 2023 Nov 7, 2022

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.